After 30 months of fast-paced innovation in quantum algorithms, six research groups are hoping to hit paydirt. But there can be only one big winner—if there is a winner at all.

Technology Review, published by MIT, is a leading source of news, analysis, and commentary on emerging technologies, scientific advancements, and their societal impacts. Covering topics such as artificial intelligence, biotechnology, renewable energy, and more, Technology Review provides  reporting and  articles on the intersection of technology and society. Readers can stay informed about the latest breakthroughs and trends shaping the future of technology.

MIT Technology Review

Six research teams are competing for a $5 million prize in the Quantum for Bio (Q4Bio) competition, run by nonprofit Wellcome Leap, to demonstrate that today's noisy, limited quantum computers can solve real-world healthcare problems. Teams must run quantum algorithms on 50+ or 100+ qubit machines to win $2M or $5M respectively, with the grand prize requiring solving a problem classical computers cannot. Finalists are tackling challenges like cancer signature identification, photodynamic drug simulation, genomic diversity mapping, and muscular dystrophy drug discovery. A key finding across all teams is the power of quantum-classical hybrid approaches, where quantum processors handle only the parts classical methods struggle to scale, while classical computers handle the rest. The program director acknowledges the grand prize is unlikely to be claimed given current hardware limitations, but notes the competition has revealed promising application areas and transformational hybrid processing advances.

A $5 million prize awaits proof that quantum computers can solve health care problems